LB Pharmaceuticals, Inc. (LBRX)
42.47
+0.33
(+0.78%)
USD |
NASDAQ |
Sep 18, 16:00
42.37
-0.10
(-0.24%)
After-Hours: 20:00
LB Pharmaceuticals Free Cash Flow : -82.83M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -82.83M |
| March 31, 2026 | -50.43M |
| December 31, 2025 | -35.26M |
| September 30, 2025 | -23.02M |
| Date | Value |
|---|---|
| June 30, 2025 | -42.13M |
| March 31, 2025 | -52.35M |
| December 31, 2024 | -53.82M |
| September 30, 2024 | -48.68M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals, Inc. | 119.83M |
| Neumora Therapeutics, Inc. | -180.96M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.63M |
| Cash from Investing (Quarterly) | 0.089M |
| Cash from Financing (Quarterly) | -0.019M |
| Free Cash Flow Per Share (Quarterly) | -1.261 |
| Free Cash Flow to Equity (Quarterly) | -39.74M |
| Free Cash Flow to Firm (Quarterly) | -37.99M |
| Free Cash Flow Yield | -7.16% |